CalciMedica (CALC) Preferred Dividend Payments (2019 - 2020)
CalciMedica's (CALC) quarterly Preferred Dividend Payments came in at -$11000.0 in Q4 2020, down 100.45% YoY from $2.4 million in Q1 2020, and down 100.46% on a QoQ basis from $2.4 million in Q3 2020.
CalciMedica (CALC) Preferred Dividend Payments (2019 - 2020) Analysis & Trends
CalciMedica (CALC) has 2 years of Preferred Dividend Payments data on file, last reported at -$11000.0 in Q4 2020.
- Quarterly Preferred Dividend Payments fell 100.45% year-over-year to -$11000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $7.2 million (changed N/A YoY) and the FY2022 annual result came in at -$1.3 million, changed N/A from the prior year.
- Preferred Dividend Payments fell to -$11000.0 in Q4 2020, from $2.4 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $3.5 million in Q2 2020 to a low of -$11000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | CalciMedica | 9.93 Mn | -8.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -11,000.00 |
| Sep 30, 2020 | 2.40 Mn |
| Jun 30, 2020 | 3.49 Mn |
| Mar 31, 2020 | 1.30 Mn |
| Dec 31, 2019 | 2.42 Mn |
| Sep 30, 2019 | 2.05 Mn |